Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on June 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ChemiDoc™ MP Imaging System

Closed
75N98026Q00382Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334516
New
Federal
CDC Notice of Intent to Sole Source for Inhalation Support / TSI MOUDI-II InstrumentThe Centers for Disease Control and Prevention (CDC) plans to award a sole-source contract for the purchase of a Micro Orifice Uniform-Deposit Impactor (MOUDI) from TSI Incorporated through simplified acquisition procedures. This procurement is justified because TSI is the only known supplier capable of providing a MOUDI instrument that meets the specific size classification requirements and the uniform sample deposition necessary for inhalation research. The contract will be a total small business set-aside under NAICS code 334516 and will support work to be performed in Morgantown, West Virginia. Interested parties are not being requested to submit competitive quotes, but those who believe they can fulfill the requirement may submit a capability statement by June 17, 2026, for consideration. The notice emphasizes that responding to this announcement does not guarantee the government will initiate a competitive procurement, and any costs incurred by responders will not be reimbursed. Questions and capability statements should be directed via email to the designated contract specialist, Aminah Gary, at the provided contact information. The decision to proceed with this sole-source acquisition rests solely with the government, which will use any received information to determine if competition is warranted. The solicitation number for this procurement is 75D301-26-Q-98063, and the official posting date is June 10, 2026.
CDC Office Of Acquisition Services

POSTED

2 days ago

DEADLINE

in about 24 hours

AI Contract Overview

Show more

The Department of Health and Human Services, specifically the National Institutes of Health in Bethesda, Maryland, is soliciting bids for the purchase of a ChemiDoc™ MP Imaging System. This solicitation, issued on June 1, 2026, under the number 75N98026Q00382, aims to acquire a high-sensitivity imaging instrument used in molecular biology for documenting and quantifying results from assays such as chemiluminescent and fluorescent blot imaging and gel documentation. The system, manufactured exclusively by Bio-Rad, is crucial for the research lab of Dr. Chittiboina to improve data accuracy, throughput, and compliance with recordkeeping standards. The ChemiDoc MP system supports a range of imaging applications including fluorescent and chemiluminescent western blots, and is intended to replace older shared equipment that currently limits access and causes variability in data acquisition. The contract will be awarded as a firm fixed price agreement, with proposals due by June 15, 2026, at 9:00 AM EDT. Award decisions will consider technical capability, past performance, and cost, with technical and past performance factors carrying greater weight than price. The purchase will prioritize Bio-Rad due to their pricing advantage over other suppliers, with delivery expected within seven days of contract award. The procurement follows Federal Acquisition Regulations parts 12 and 13 for commercial items, and all necessary certifications and representations must be submitted by offerors. The point of contact for this solicitation is Towanda Daniels, Purchasing Agent at the NIH, who can be reached via email for further inquiries.

General Info

NIH seeks bids for Bio-Rad ChemiDoc MP Imaging System; proposals due June 15, 2026.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(1)

Statement of Need for ChemiDoc MP Imaging System 75N9802Q00382

PDFstatement-of-need

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
Office AddressBETHESDA, MD, 20892, USA
Contacts
Towanda Daniels

Full Description

Show more

COMBINED SYNOPSIS / SOLICITATION 


  1. Action Code: Combined Synopsis/Solicitation
  2. Date: June 1
  3. Year: 2026
  4. Contracting Office Zip Code: 20892
  5. Classification Code: 6640
  6. Contracting Office Address: 6701 Rockledge Drive Bethesda, MD 20817
  7. Subject/Title: ChemiDoc™ MP Imaging System
  8. Solicitation Number: 75N98026Q00382
  9. Closing Response Date: June 15, 2026 @ 9am. Eastern Daylight Time (EDT)
  10. Contact Point(s): Towanda Daniels, Purchasing Agent
  11. Contract Award Type: Firm Fixed Price
  12. Contract Award: TBD
  13. Contract Award Dollar Amount: TBD
  14. Contract Line Item Number(s): TBD
  15. Contractor Award Date: TBD
  16. Contractor Name: TBD
  17. Brand Name or Equal Acquisition (FAR 52.211-6): Yes
  18. Description: See attached.  

    PURCHASE DESCRIPTION


    1. Statement of Need and Purpose: The research lab of Dr. Chittiboina requires a ChemiDoc™ MP Imaging System to reliably document and quantify results from routine molecular biology workflows, including chemiluminescent and fluorescent blot imaging and gel documentation. This instrument will provide high-sensitivity, reproducible imaging needed for accurate data capture, compliance-ready recordkeeping, and efficient experiment throughput. Purchasing the system from BioRad supports continuity with established Bio-Rad platform compatibility and service/support expectations for lab operations. Dr. Chittiboina intend to buy this instrument to fulfil the research requirements.


    2. Background Information and Objective: The intent of this order is to purchase the ChemiDoc™ MP Imaging System manufactured by Bio-Rad, 2000 Alfred Nobel Drive, Hercules, CA 94547. Current imaging access is limited and/or relies on older shared equipment, creating bottlenecks and variability in data acquisition for protein and nucleic acid analyses. The objective of acquiring the ChemiDoc™ MP Imaging System is to strengthen the lab’s capability to standardize imaging conditions, improve quantitative accuracy, and reduce turnaround time for experimental documentation. This will enhance the quality and traceability of research outputs and support ongoing and future studies requiring robust gel and blot imaging. The ChemiDoc MP Imaging System is a full-feature, best in class instrument for imaging and quantifying nucleic acid and protein in gels and western blots. It is capable of imaging fluorescent western blots (RGB, far-red, near-IR), chemiluminescent western blots, all common nucleic acid and protein gel stains, plus stain-free gels.


    Generic Name of Product: Catalog # 12003154: ChemiDoc™ MP Imaging System. Includes: White and Blue for ChemiDoc™ MP/ChemiDoc Imaging Systems, StarBright Blue 700 Goat Anti- Rabbit IgG, 80 μl, hFAB™ Rhodamine Anti-Tubulin Primary Antibody 40 μl



    Purchase Description: Manufactured by Bio-Rad, 2000 Alfred Nobel Drive, Hercules, CA 94547.


    Salient characteristics: These items are manufactured only by BIORAD. We have the quote from Government Scientific Source, Inc for the same item with a price difference. We prefer to place the order to BIORAD as the company is providing a cheaper price than GSS.


    4. Quantity: One item


    5. Delivery Date: As soon as possible within a frame of 7 days.


    6. Period of Performance: Not applicable


    7. Option(s): Not applicable

  19. “This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.”
  20. The solicitation number and a statement that the solicitation is issued as a request for quote (RFQ).
  21. The solicitation document, the incorporated provisions, and clauses are those in effect through Federal Acquisition Circular, FAC Number: 2026-01 Effective Date: 03/13/2026

This solicitation is being released unrestricted. The NAICS code is 334516, and the small business size standard is 1,000. This acquisition is being conducted in accordance with the procedures of FAR Part 12 and FAR Part 13.


The Statement of Need and any terms and conditions relevant to the requirement are included as attachments.


The provisions at FAR Clause 52.212-1, Instructions to Offerors – Commercial Items, applies to this acquisition. The following addendum related to the Instructions to Offerors is included:


Addendum to FAR Clause 52.212-1, Instructions to Offerors – Commercial Items. Please refer to this addendum for additional attachments, including the Statement of Work and other relevant information.


Evaluations will be conducted in accordance with the provision at FAR Clause 52.212-2. Offerors will be evaluated as follows:


Evaluation-Commercial Items (Oct 2014)


  1. The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers:

    • Technical: 
    • Past Performance
    • Cost

All evaluation factors other than cost or price, when combined are significantly more important than cost or price.


Written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award.


Please refer to the addendum for additional evaluation information.


Each Offeror must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications – Commercial Items, with its offer.


Please note, each Offeror shall complete only paragraph (b) of this provision if the Offeror has completed the annual representations and certification electronically via the System for Award Management (SAM) website located at


https://www.sam.gov/portal.


FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Items, applies to this acquisition. The terms and conditions outlined in the following addendum also apply:


  • Addendum to FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Items. Please refer to this addendum for additional terms and conditions related to the requirement.

FAR Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders – Commercial Items, applies to this acquisition. The full text version of FAR 52.212-5 included in the addenda as Attachment 5 indicate which FAR clauses and provisions are applicable to this acquisition.


Contact Information:


Purchasing Agent: Towanda Daniels


Email: danielt@mail.nih.gov



  1. Place of Contract Performance: Bethesda, MD
  2. Set-aside Status: N/A